APOGEE THERAPEUTICS, INC. COMMON STOCK
NASDAQ: APGE (Apogee Therapeutics, Inc.)
Kemas kini terakhir: 1 jam lalu134.75
0.00 (0.00%)
| Penutupan Terdahulu | 134.75 |
| Buka | 134.81 |
| Jumlah Dagangan | 948,282 |
| Purata Dagangan (3B) | 2,787,561 |
| Modal Pasaran | 10,198,922,240 |
| Harga / Buku (P/B) | 8.54 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 9 Nov 2026 |
| EPS Cair (TTM) | -3.61 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.75% |
| Nisbah Semasa (MRQ) | 15.82 |
| Aliran Tunai Operasi (OCF TTM) | -188.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -120.81 M |
| Pulangan Atas Aset (ROA TTM) | -19.65% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Apogee Therapeutics, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.50 |
|
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 7.62% |
| % Dimiliki oleh Institusi | 137.71% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Venrock Adviser, Llc | 30 Jun 2026 | 8,493,321 |
| Hbk Investments L P | 30 Jun 2026 | 2,850,000 |
| Fmr Llc | 30 Jun 2026 | 2,493,137 |
| Driehaus Capital Management Llc | 30 Jun 2026 | 1,740,101 |
| Balyasny Asset Management L.P. | 30 Jun 2026 | 1,665,102 |
| Glazer Capital, Llc | 30 Jun 2026 | 1,641,042 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |